Life & Health

One in four Americans is caring for a loved one with a debilitating illness or other special needs. COVID-19 amplified the problem, and it will continue to grow. 

Perhaps no technology imagined by Star Trek has enticed more international interest than the medical tricorder.

Advancements in machine learning are changing the landscape of the life insurance industry, making life settlements more accessible to policyholders.

The anti-vaccination movement has resulted in 1 out of 10 American parents delaying or outright refusing necessary childhood vaccinations.

You are passing up maybe $1,000 in commissions per client if you aren't cross-selling instant-issue term life insurance policies that don't require a medical checkup.

Although the life insurance industry has been cautious by nature, data and technology are shifting the analysis of risk and enabling prudent underwriting without volatility.

The technology for liquid biopsies is developing rapidly, showing potential for multiple clinical applications, including new cancer screening tests.

A cross-disciplinary study using digital health data may have serious implications for mortality from sleep apnea -- and for insurers seeking to underwrite these risks.